Immunovant, Inc. (IMVT) NASDAQ
24.41
-0.58(-2.32%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
24.41
-0.58(-2.32%)
Currency In USD
| Market Cap | 2.59B |
| Enterprise Value | 1.88B |
| P/E Ratio | -9.54 |
| PEG Ratio | -1.81 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.49 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -8.25 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.44 |
| Return On Equity | -0.66 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -437.78M |
| Net Income | -413.84M |
| Diluted EPS | -2.73 |
| Total Cash | 994.53M |
| Total Cash/Share | 5.48 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 15.74 |
| Book Value Per Share | 5.43 |
| 52-Week Change | 25.05 |
| 52-Week High | 29.25 |
| 52-Week Low | 12.72 |
| Moving Average 50 Days | 26.27 |
| Moving Average 200 Days | 20.57 |
| Average Volume | 1.46M |
| Shares Outstanding | 203.53M |
| % Held by Institutions | 62.55 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |